Melanoma

Double click on above image to view full picture

Zoom Out
Zoom In

Melanoma

SKU# 9781936287796

Series: Emerging Cancer Therapeutics V3 I2

William H. Sharfman MD
Jame Abraham MD, FACP

$119.00

Other Vendors:

Amazon

Buy eBook:

Amazon Kindle | iBooks

Description

Emerging Cancer Therapeutics is a trinary hard cover periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum.

With contributions from nationally recognized experts representing the fields of dermatology, dermatologic surgery, surgical oncology, dermatopathology, and medical oncology, Melanoma includes chapters on prevention, changes in melanoma staging, the evolving role of established surgical therapies, single-agent specific V600E mutant inhibitors, target therapy for patients without BRAF mutations, new treatments for metastatic melanoma-including ipilimumab and vemurafenib-and more.

"

Product Details

  • Publication Date December 17, 2012
  • Page Count 240
  • Product Form Hardback
  • ISBN 13 9781936287796
  • EISBN 9781617051616

Table of Contents

"1. Preventing Melanoma, Barbara Summerer, MD, Sewon Kang, MD, and Timothy Wang, MD, 2. Evolution of the Melanoma Staging System, Rohit R. Sharma, Glen C. Balch, and Charles M. Balch, 3. Less Common Variants of Cutaneous Melanoma, Raymond L. Barnhill and Kapil Gupta, 4. Controversies in the Management of the Regional Node Basin in Cutaneous Melanoma, Ioannis Hatzaras and Julie R. Lange, 5. Adjuvant Therapy for Melanoma, Tara C. Gangadhar and Lynn M. Schuchter, 6. RAF Kinase Inhibitor Therapy in Melanoma, James J. Harding and Paul B. Chapman, 7. Emerging Targets for Melanoma Therapy Besides BRAF, Young Kwang Chae, Sapna P. Patel, and Kevin B. Kim, 8. Ipilimumab: The New Frontier of T-Cell Antibodies: A Paradigm Shift in Immuno-Oncology, Steven J. O'Day, 9. Adoptive Cell Transfer Immunotherapy for Patients with Metastatic Melanoma, Crystal J. Hessman, Ashley A. Stewart, Akemi D. Miller, James C. Yang, and Steven A. Rosenberg, 10. Immunotherapies for Metastatic Melanoma, Kevin Conlon, 11. Updated Approach to the Patient with Metastatic Melanoma, Rodabe N. Amaria and Rene Gonzalez; ; "